GlassScriptPhysician profile
Adeola Oviawe
NPI 1053775239
$956.74
in general payments reported to CMS, 2019-2025
20 companies · $227 in 2025
The $227 reported for 2025 was more than what 78% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $80.49 · 2022: $227 · 2023: $52.31 · 2024: $243 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $134.02 | 2019-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $117.86 | 2022-2025 | |
| Glaxosmithkline, LLC. | $116.12 | 2022 | |
| Pfizer INC. | $86.78 | 2024-2025 | |
| Sunovion Pharmaceuticals INC. | $79.79 | 2019 | |
| Lilly USA, LLC | $73.51 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Amgen INC. | $69.10 | 2022-2025 | Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $51.99 | 2022-2025 | Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.13 | 2022 | |
| Allergan, INC. | $22.75 | 2020 | |
| Medtronic, INC. | $22.44 | 2025 | Minimed 780g |
| Abbott Laboratories | $20.46 | 2024 | Freestyle Libre 3 |
| Corium, LLC | $19.19 | 2025 | Azstarys |
| Amarin Pharma, INC. | $18.94 | 2020 | |
| Tempus Ai, INC | $18.55 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $18.47 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.40 | 2019 | |
| Exact Sciences Corporation | $17.79 | 2024 | Cologuard Collection Kit |
| Tactile Systems Technology INC | $14.34 | 2025 | Flexitouch Plus, Nimbl |
| Gilead Sciences, INC. | $11.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adeola Oviawe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.